17 results
6-K
EX-99.3
IINN
Inspira Technologies Oxy B.H.N. Ltd
27 Feb 24
Report of Foreign Private Issuer
7:15am
Director Senior Intensive Care physician at Tel Aviv Sourasky Medical Center. Chairman of the Israeli ECMO Society Team
See Disclaimers on slides 1 - 16
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
8 Aug 22
Copyright © 2018 - 2022 Inspira Technologies OXY B.H.N. LTD., All rights reserved August 2022 Investor Presentation
9:17am
American Thoracic Society 2. Diling Wu et al. Frontiers in pharmacology MINI REVIEW published: 09 May 2019. doi: 10.3389/fphar.2019.00482 3. Kalil AC … by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63:e61 - e111. MV requires intrusive intubation
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
6 Apr 22
Inspira Technologies Announces Deployment Agreement in the Israeli Market to Target $15M
9:25am
we believe is destined to become a new category of care for the acute respiratory failure market.”
Yigal Kassif, MD. Chairman of Israeli ECMO Society
20-F
bt3hsgxw
31 Mar 22
Annual report (foreign)
4:48pm
6-K
EX-99.1
8y7h298xo u2izoahx8x
1 Feb 22
Report of Foreign Private Issuer
8:58am
6-K
EX-99.1
7htgi37qwj
6 Jan 22
Report of Foreign Private Issuer
6:47am
6-K
EX-99.1
t2b02
30 Nov 21
Prof. Fan currently serves as the medical director of the extracorporeal life support program at the Toronto General Hospital
8:34am
6-K
EX-99.1
038533 io4
12 Oct 21
Report of Foreign Private Issuer
4:01pm
6-K
EX-99.1
nc3f7fk g6tl06mrb
13 Sep 21
Report of Foreign Private Issuer
4:01pm
424B4
nh0zi0umsblg
15 Jul 21
Prospectus supplement with pricing info
4:06pm
F-1/A
m0u8z4si1k27oowwm
1 Jul 21
Registration statement (foreign) (amended)
11:58am
FWP
742dc g6sp
28 Jun 21
Free writing prospectus
11:45am
F-1/A
dzr2zma0nu
28 Jun 21
Registration statement (foreign) (amended)
11:41am
FWP
p77st4awnwg bsu7c
9 Jun 21
Free writing prospectus
6:17am
F-1/A
iojdyvq08nxr
8 Jun 21
Registration statement (foreign) (amended)
5:26pm
- Prev
- 1
- Next